Brief: Orion, Newel Health Enter Into Licensing Agreement
29/01/2024 10:23
Jan 29 (Reuters) - Orion Corp 271560.KS :
* ORION CORPORATION AND NEWEL HEALTH ENTER INTO LICENSING
AGREEMENT FOR A DIGITAL THERAPEUTIC (DTX) ODD-403 (“ROHKEA”) IN
PAIN
* NEWEL WILL HAVE EXCLUSIVE GLOBAL RIGHTS TO DEVELOP,
MANUFACTURE
AND COMMERCIALISE ODD-403.
Source text for Eikon: ID:nGNEMfW4b
Further company coverage: 271560.KS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Orion
See all newsBrief: Flashlight Capital Partners A Shareholder Of Orion Corp. Today Sent An Open Letter To Orion's Board With Five Requests
Brief: Orion To Spend 69 Billion Won On Dividend
Health Rounds: Veracyte genomic test identifies breast cancer patients who can skip chemo
Brief: Orion Corp 2025 Operating Profit 558.2 Billion Won, Up 2.7% From Year Earlier
Brief: Orion Corp To Invest 228 Billion Won In Building A Factory In Jincheon County, South Korea